BioMarin Pharmaceutical | BMRN - 贸易债权人

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.15B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	贸易债权人	更改		日
Acadia Pharmaceuticals	USD 10.9M		10.84M	2025-12
Agios Pharmaceuticals	USD 13.75M		4.61M	2026-03
Alnylam Pharmaceuticals	USD 115.72M		1.87M	2025-12
Amgen	USD 20.89B		1.25B	2025-12
Bayer	EUR 7.08B		700M	2025-12
Biogen	USD 358.5M		73.5M	2026-03
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Gilead Sciences	USD 715M		93M	2025-12
Incyte	USD 228.62M		1.41B	2026-03
Insmed	USD 79.91M		316K	2025-12
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
Moderna	USD 317M		50M	2025-12
Neurocrine Biosciences	USD 545.5M		425.6M	2025-12
PTC Therapeutics	USD 45.49M		8.87M	2025-12
Puma Biotechnology	USD 6.39M		962K	2025-09
Regeneron Pharmaceuticals	USD 1.03B		4.81B	2026-03
Roche Holding	CHF 5.78B		1.27B	2025-12
Sangamo BioSciences	USD 10.74M		7.46M	2025-06
Sanofi	EUR 22.93B		2.89B	2025-12
Sarepta Therapeutics	USD 280.84M		186.83M	2025-12
Ultragenyx Pharmaceutical	USD 40.57M		6.33M	2025-09
United Therapeutics	USD 7.1M		460.9M	2025-12
Vertex Pharmaceuticals	USD 3.43B		600.9M	2025-12